Biomobie collaborates with People Daily Health Client, Cardiovascular Channel, now online!

On April 7th, Biomobie (Shanghai) Regenerative Medicine Co., Ltd. joined forces with People's Daily Health Client Cardiovascular Channel for the launch of the "National Active Health 6668 Employee Care Plan."

Ge Junbo, member of the National Committee of the Chinese People's Political Consultative Conference, academician of the Chinese Academy of Sciences, and director of the Cardiology Department at Zhongshan Hospital affiliated with Fudan University, emphasized the dual pressures of aging population and chronic disease prevention and control in China. He highlighted the importance of preventing cardiovascular diseases, stating that the launch of the Cardiovascular Channel on the People's Daily Health Client provides a new platform for health education in the field of cardiovascular prevention and treatment in China.

Figure：Biomobie CEO Jack Wang (far right) participating with experts in the launch of the People's Daily Health Client Cardiovascular Channel

Figure：Ge Junbo, member of the Standing Committee of the National Committee of the Chinese People's Political Consultative Conference, academician of the CAS Member, director of cardiology department of Zhongshan Hospital affiliated to Fudan University

In his speech, Academician Ge Junbo emphasized that medical innovation, whether in technology, drugs, instruments, or concepts, should be centered around the health of the people. He called for innovation that addresses the most urgent needs of patients or doctors, creating an innovative model that involves concepts, products, industries, disciplines, and ecology.

Figure: Wu Jing, Director of the Chronic Disease Center of the China Center for Disease Control and Prevention

Wu Jing, Director of the Chronic Disease Center at the Chinese Center for Disease Control and Prevention, shared the epidemiological characteristics and prevention and control of cardiovascular diseases in China. She emphasized that effective management of cardiovascular diseases is crucial, given their heavy burden, wide-ranging impact, and the challenges associated with prevention and control.

Figure：Huo Yong, Executive Chairman of the China Chest Pain Center Alliance and Chief Physician of Cardiology at Peking University First Hospital

Huo Yong, Chairman of the China Chest Pain Center Alliance and Chief Physician of the Cardiology Department at Peking University First Hospital, delivered a keynote speech, proposing the combination of active health and prevention and treatment to support the expansion and sinking of new technologies for cardiovascular prevention and treatment.

Figure：Gai Haishan, Deputy Secretary of the Party Committee, Secretary of the Discipline Inspection Commission, and Chief Expert in Preventive Medicine at Beijing Rehabilitation Hospital, and Deputy Director of the National Committee for the Promotion of Employee Health Projects

Gai Haishan, Deputy Secretary of the Party Committee, Discipline Inspection Secretary, and Chief Expert of Preventive Medicine at Beijing Rehabilitation Hospital, suggested the use of administrative interventions in the health guarantee measures for employees, emphasizing the importance of health management in enterprises.

Figure：“Roundtable Dialogue on "Technological Innovation: Biomobie CEO Wang Jian Participates in Promoting High Quality Development of Cardiovascular Disease Treatment"

The event also featured a roundtable discussion on "Technological Innovation: Advancing the High-Quality Development of Cardiovascular Disease Treatment," where participants explored ways to amplify China's innovative achievements in basic research and clinical translation in the field of cardiovascular diseases.

The activity was hosted by People's Daily Health Client, with the public support of Biomobie (Shanghai) Regenerative Medicine Technology Co., Ltd.

Article source: People's Daily Health Client